Anwar I - Search Results

1

Implications of risk conferred by 5p15.33 loci genetic variants; human telomerase reverse transcriptase rs2736098 and rs2736100 in predisposition of bladder cancer.

Anwar I, Pandith AA, Mir H, Manzoor U, Amin I, Baba SM, Godha M, Koul AM, Shah ZA, Mansoor S, Wani MS. Anwar I, et al. Rep Pract Oncol Radiother. 2022 Oct 31;27(5):787-796. doi: 10.5603/RPOR.a2022.0082. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36523804 Free PMC article.

2

Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases.

Pandith AA, Wani ZA, Qasim I, Afroze D, Manzoor U, Amin I, Baba SM, Koul A, Anwar I, Mohammad F, Bhat AR, Shah P. Pandith AA, et al. Among authors: anwar i. J Gene Med. 2020 Nov;22(11):e3260. doi: 10.1002/jgm.3260. Epub 2020 Aug 28. J Gene Med. 2020. PMID: 32783258

3

Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma.

Pandith AA, Qasim I, Baba SM, Koul A, Zahoor W, Afroze D, Lateef A, Manzoor U, Bhat IA, Sanadhya D, Bhat AR, Ramzan AU, Mohammad F, Anwar I. Pandith AA, et al. Among authors: anwar i. Future Sci OA. 2020 Dec 9;7(3):FSO663. doi: 10.2144/fsoa-2020-0057. Future Sci OA. 2020. PMID: 33552543 Free PMC article.

4

Influence of prominent immunomodulatory cytokines TNF-α308 G>A (rs1800629) and TGFβ1 G>C (rs1800471) sequence variations as an important contributing factor in etiopathogenesis of recurrent miscarriages in Kashmiri women (North India).

Manzoor U, Pandith AA, Amin I, Wani S, Sanadhya D, Ahmad A, Qasim I, Rashid M, Anwar I, Koul A. Manzoor U, et al. Among authors: anwar i. J Obstet Gynaecol Res. 2021 May;47(5):1686-1693. doi: 10.1111/jog.14718. Epub 2021 Feb 23. J Obstet Gynaecol Res. 2021. PMID: 33624323

5

Implications of VEGF gene sequence variations and its expression in recurrent pregnancy loss.

Amin I, Pandith AA, Manzoor U, Mir SH, Afroze D, Koul AM, Wani S, Ahmad A, Qasim I, Rashid M, Wani UM, Anwar I, Aein QU, Mansoor S. Amin I, et al. Among authors: anwar i. Reprod Biomed Online. 2021 Dec;43(6):1035-1044. doi: 10.1016/j.rbmo.2021.08.009. Epub 2021 Aug 20. Reprod Biomed Online. 2021. PMID: 34716101

6

Analysis of MNS16A VNTR polymorphic sequence variations of the TERT gene and associated risk for development of bladder cancer.

Anwar I, Pandith AA, Wani MS, Mir H, Godha M, Koul A, Shah ZA, Manzoor U, Amin I, Qasim I. Anwar I, et al. Curr Urol. 2021 Dec;15(4):225-230. doi: 10.1097/CU9.0000000000000040. Epub 2021 Sep 17. Curr Urol. 2021. PMID: 35069087 Free PMC article.

7

Implications of Decreased Expression of miR-125a with Respect to Its Variant Allele in the Pathogenesis of Recurrent Pregnancy Loss: A Study in a High Incidence Zone.

Manzoor U, Pandith AA, Amin I, Wani S, Sanadhya D, Lone TA, Mir H, Paray BA, Gulnaz A, Anwar I, Ahmad A, Aein QU. Manzoor U, et al. Among authors: anwar i. J Clin Med. 2022 Jul 1;11(13):3834. doi: 10.3390/jcm11133834. J Clin Med. 2022. PMID: 35807118 Free PMC article.

8

Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.

Mir MA, Pandith AA, Mansoor S, Baba SM, Makhdoomi R, Ain QU, Anwar I, Para SA, Bhat AH, Koul AM, Manzoor U, Khan I, Beg A, Wani MS. Mir MA, et al. Among authors: anwar i. Gene. 2023 Aug 20;878:147583. doi: 10.1016/j.gene.2023.147583. Epub 2023 Jun 22. Gene. 2023. PMID: 37353040

9

Regulatory role of miR-125a expression with respect to its target genes LIFR, ERBB2 and STAT3 in the pathogenesis of recurrent pregnancy losses.

Manzoor U, Pandith AA, Amin I, Wani S, Baba SM, Wani UM, Mansoor S, Aein QU, Anwar I, Bahar B, Koul AM, Sanadhya D, Ahmad A. Manzoor U, et al. Among authors: anwar i. Int J Gynaecol Obstet. 2024 Sep;166(3):1285-1296. doi: 10.1002/ijgo.15496. Epub 2024 Mar 25. Int J Gynaecol Obstet. 2024. PMID: 38528801

10

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.

Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters